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Introduction {#s1}
============

Stroke is the second most common cause of death and the leading cause of serious, long-term disability worldwide [@pone.0107498-Bonita1]. The burden of stroke is high and growing in economically developing countries [@pone.0107498-Yusuf1]. In China, stroke accounts for 21.6% of total mortality in males and 20.8% of total mortality in females [@pone.0107498-He1]. The total incidence of stroke is projected to increase considerably over the next two decades [@pone.0107498-Meairs1].

Homocysteine (Hcy), a sulphur-containing amino acid, was hypothesized to affect atherosclerotic processes as early as 1969 [@pone.0107498-McCully1]. Since that time, numerous epidemiological studies have demonstrated a positive association between Hcy level and stroke incidence [@pone.0107498-Khan1]--[@pone.0107498-Wald1]. A meta-analysis of prospective studies supports the possibility that the association between plasma Hcy and stroke may be causal: a 5 µmol/l Hcy elevation causes a 59% increase in stroke risk, while a 3 µmol/l Hcy reduction leads to a 24% decrease in stroke risk [@pone.0107498-Wald1]. Previous research has found that elevated Hcy is associated with poor outcome among acute ischemic stroke patients [@pone.0107498-Tu1]--[@pone.0107498-Wu1], but inconsistent results still exist [@pone.0107498-Song1]--[@pone.0107498-Perini1]. A study in a Korean population, after a 12-month follow-up, shows that plasma Hcy levels have no value as predictors of functional outcome [@pone.0107498-Song1].

Epidemiological studies have documented that high blood pressure (BP) is the most important modifiable risk factor for the incidence of stroke [@pone.0107498-Qizilbash1], [@pone.0107498-Eastern1]. In China, hypertensive patients usually have high homocysteine (hHcy) concentration levels and the proportion is about 75%. A large sample of epidemiological research demonstrated that the incidence of cardiovascular events in hypertensive patients with high Hcy is about 5 times higher than in patients with hypertension alone, and about 25--30 times higher than in those without hypertension [@pone.0107498-Graham1]. And a nationwide study showed elevated total plasma homocysteine and hypertension had a multiplicative effect on the odds of prevalent stroke [@pone.0107498-Towfighi1]. Few studies to date have examined the cumulative effect of high BP at admission and Hcy concentration on poor outcome among stroke patients, especially in a northern Chinese population.

Thus, we sought to assess the relationship between high plasma homocysteine, blood pressure and poor discharge outcome among acute ischemic stroke patients. We also examined if hHcy may increase the risk of poor outcome based on high BP status in a northern Chinese population.

Methods {#s2}
=======

Study participants {#s2a}
------------------

From June 1, 2009 to May 31, 2013, we recruited adult patients with a clinical diagnosis of acute ischemic stroke from three hospitals in northern cities in China (the People\'s Hospital of XingAnMeng in Inner Mongolia, the Center Hospital of FuXin in LiaoNing province and ChengDe Medical College Affiliated Hospital in HeBei province). All participants were recruited within 7 days of symptom onset. Exclusion criteria were: (1) lack of plasma homocysteine concentration measurement; (2) lack of blood pressure data; (3) presence of illnesses including renal and kidney disease, malignancy, autoimmune disease, and hypothyroidism; and (4) inability to comply with a magnetic resonance examination.

Ethics Statement {#s2b}
----------------

This study was approved by the Soochow University Ethics Committee. Written informed consent was obtained from all study participants.

Data Collection {#s2c}
---------------

Demographic characteristics, lifestyle risk factors, medical history, clinical laboratory tests and imaging data (CT and MRI) were recorded within the first 24 h after admission to hospital by a face to face interview with patients or their family members (if patients were not able to communicate). All information was obtained using a standard questionnaire administered by trained staff. Cigarette smoking was defined as having smoked at least 1 cigarette per day for 1 year or more. The amount and type of alcohol consumed during the past year were collected. Alcohol consumption was defined as consuming one or more alcoholic drink per day during the last year. Blood pressure (BP) was measured in the first 72 h (one measurement every 8 h) after admission while the participants were in the supine position using a standard mercury sphygmomanometer according to a standard protocol. The first and fifth Korotkoff sounds were recorded as systolic (SBP) and diastolic BP (DBP), respectively. High admission BP was defined as SBP ≥140 mmHg and/or DBP ≥90 mmHg. History of hypertension was defined that patients have hypertension prior to admission to hospital, according to the question "have you received a diagnosis of hypertension from any doctor or hospital before this onset of stroke", or use of antihypertensive medication, or SBP ≥140 mmHg and/or DBP ≥90 mmHg.

Hcy, total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol and triglycerides were analyzed on a Beckman Synchron CX5 Delta Clinical System (Beckman Coulter, Inc., Fullerton, California, USA) using commercial reagents [@pone.0107498-Allain1]. Plasma glucose was measured by a modified hexokinase enzymatic method [@pone.0107498-Lloyd1]. The criterion of dyslipidemia was as follows: total cholesterol ≥6.22 mmol/l or triglyceride ≥2.26 mmol/l or LDL cholesterol ≥4.14 mmol/l or HDL cholesterol \<1.04 mmol/l. Hyperglycemia was defined as fasting plasma glucose ≥6.1 mmol/l. High Hcy (hHcy) was defined as Hcy\>15 umol/l, and nhHcy was Hcy ≤15 umol/l [@pone.0107498-Refsum1], [@pone.0107498-Refsum2].

Acute ischemic stroke was confirmed by imaging (CT scan or MRI) according to the acute ischemic stroke diagnosis and treatment guidelines in China. Study outcome was evaluated using the modified Rankin Scale (mRS) obtained at hospital discharge, and poor outcome was defined as a mRS score ≥3 or death. Scores on the modified Rankin Scale range from 0 to 6, with a score of 0 indicating no symptoms; a score of 5 indicating severe disability (i.e., bedridden, incontinent, or requiring constant nursing care and attention); and a score of 6 indicating death [@pone.0107498-Bonita2].

Statistical analysis {#s2d}
--------------------

Statistical analysis was conducted using SAS statistical software (version 9.1, Cary, North Carolina, USA). Patients were divided into two groups according to study outcome: mRS \<3 and mRS ≥3 or death. According to blood pressure and concentration level of Hcy, participants were divided into four groups: non-high BP with non-hHcy (nhHcy), non-high BP with hHcy, high BP with nhHcy, and high BP with hHcy. Baseline characteristics of continuous variables were compared in 2 or 4 subgroups using Student\'s t-test or ANOVA. Categorical variables were expressed as percentage and compared between groups using Chi-square test. Plasma Hcy concentration was divided into four quartiles (\<11.9 µmol/l, 11.9--16.1 µmol/l, 16.1--23.3 µmol/l, ≥23.3 µmol/l; \<11.9 µmol/l is the lowest quartile and ≥23.3 µmol/l is the highest quartile). Univariate and multivariate non-conditional logistic regression models were used to assess the association between Hcy, blood pressure and discharge outcome among acute ischemic stroke patients. Odd ratios (ORs) and 95% confidence intervals (95% CIs) were used to evaluate the risk of poor outcome after adjusting for important confounding factors. Multivariable interaction models were used to evaluate the interaction of Hcy and blood pressure with poor outcome among acute ischemic stroke patients. All P values were 2-tailed, and a significance level of 0.05 was used.

Results {#s3}
=======

A total of 3695 patients (2381 males and 1314 females) were included in this study. The mean age of the participants was 62.40±11.45 years. [Table 1](#pone-0107498-t001){ref-type="table"} shows baseline characteristics at admission in patients with good outcome (mRS  = 0,1,2) and poor outcome (mRS  = 3,4,5 or dead). Age, high BP percentage, hospitalized days and SBP were higher in the poor outcome group whereas onset to hospital admission time, TG, TC, LDL cholesterol and proportion of dyslipidemia were higher in the good outcome group. There were no significant differences in Hcy and other variables between the two groups.

10.1371/journal.pone.0107498.t001

###### Baseline characteristics of acute ischemic stroke patients with good outcome or poor outcome.

![](pone.0107498.t001){#pone-0107498-t001-1}

                                              Good outcome (mRS  = 0,1,2)   Poor outcome (mRS  = 3,4,5 or dead)   P-value
  ------------------------------------------ ----------------------------- ------------------------------------- ---------
  N                                                      3105                               590                  
  Age                                                 62.14±11.27                       63.77±12.27                0.006
  Male no,%                                           2009,64.70                         372,63.05                 0.442
  Days hospitalized (days)                            13.21±7.71                        16.94±12.00               \<0.001
  Onset to hospital admission time (hours)            48(18,106)                         48(10,96)                 0.001
  Smoker no,%                                         1184,38.13                         226,38.31                 0.937
  Drinker no,%                                         980,31.56                         170,28.81                 0.186
  Admission SBP (mmHg)                               145.61±27.66                      148.55±23.57                0.007
  Admission DBP (mmHg)                                88.33±13.15                       89.36±13.11                0.081
  High BP no,%                                        1593,51.30                         360,61.02                \<0.001
  History of Hypertension no,%                        2054,66.15                         398,67.46                 0.538
  History of Hyperglycemia no,%                        615,19.81                         115,19.49                 0.860
  History of coronary heart disease no,%               406,13.08                         94,15.93                  0.063
  History of atrial fibrillation, no,%                  50,1.61                           16,2.71                  0.064
  Glucose (mmol/l)                                     6.75±3.63                         6.63±3.09                 0.435
  Hyperglycemia no,%                                  1285,41.38                         244,41.36                 0.989
  TG (mmol/l)                                          1.79±1.39                         1.53±1.62                \<0.001
  TC (mmol/l)                                          4.84±1.79                         4.60±1.19                \<0.001
  LDL cholesterol (mmol/l)                             3.14±0.87                         3.02±0.97                 0.007
  HDL cholesterol (mmol/l)                             1.12±0.30                         1.10±0.28                 0.135
  Dyslipidemia no,%                                   1766,56.88                         305,51.69                 0.020
  Hcy (umol/l)                                        20.40±15.31                       21.78±17.23                0.071

All values are expressed with mean±standard deviation unless otherwise noted. SBP, systolic blood pressure; DBP, diastolic blood pressure; BP, blood pressure; TG, triglycerides; TC, total cholesterol; LDL, low-density lipoprotein; HDL, high-density lipoprotein; Hcy, homocysteine.

[Table 2](#pone-0107498-t002){ref-type="table"} shows that there was a significant association between Hcy concentration and risk of poor outcome. Compared with patients in the lowest quartile of Hcy concentration, those in the highest quartile faced an increased risk of poor outcome (OR = 1.29, *P*\<0.05). After adjustment for age, gender, days hospitalized, onset to hospital admission time, smoking, drinking, history of hypertension, history of hyperglycemia, history of coronary heart disease, history of atrial fibrillation, high BP, hyperglycemia, and dyslipidemia, those in the highest quartile still had an increased risk of poor outcome (OR = 1.33, *P*\<0.05). The dose-response relationship between Hcy concentration and risk of poor outcome remained significant after adjustment for other covariates (p-value for trend  = 0.027).

10.1371/journal.pone.0107498.t002

###### Odd ratio (OR) and 95% confidence interval (CI) of poor outcome by quartiles of homocysteine level among acute ischemia stroke patients.

![](pone.0107498.t002){#pone-0107498-t002-2}

                                         Unadjusted   Multivariable Adjusted[\*](#nt102){ref-type="table-fn"}                             
  ------------------- ----- ----------- ------------ --------------------------------------------------------- ------- ------ ----------- -------
  ≤11.9                943   136,14.42      1.00                                \-                                      1.00      \-      
  11.9∼16.1            914   136,14.88      1.04                             0.80∼1.34                          0.780   1.07   0.82∼1.40   0.628
  16.1∼23.3            924   155,16.77      1.20                             0.93∼1.54                          0.162   1.19   0.91∼1.55   0.218
  \>23.3               914   163,17.83      1.29                             1.01∼1.65                          0.046   1.33   1.02∼1.75   0.036
  P-value for trend                                                            0.025                                             0.027    

\*Multivariable model adjusted for age, gender, days hospitalized, onset to hospital admission time, smoking, drinking, history of hypertension, history of hyperglycemia, history of coronary heart disease, history of atrial fibrillation, high BP, hyperglycemia, and dyslipidemia.

As shown in [Table 3](#pone-0107498-t003){ref-type="table"}, ORs of poor outcome were significant in patients with an onset to hospital admission time\>96 hours, those with a history of hypertension, and those with dyslipidemia. The ORs (95%CIs) were 1.32 (1.04--1.68), 1.17 (1.02--1.33) and 1.23 (1.06--1.44), respectively.

10.1371/journal.pone.0107498.t003

###### Sub-group analysis on the association between plasma homocystein and poor outcome among acute ischemic stroke patients.
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                                         NO. of participants   Poor outcome n,%                         
  ------------------------------------- --------------------- ------------------ ---------- ----------- ------------------
  Age, y                                                                                                
  ≤62                                            967                 957          131,13.6   144,15.0    1.06(0.93--1.22)
  \>62                                           685                 1086         112,16.4   203,18.7    1.11(0.94,1.30)
  Gender                                                                                                
  Male                                           846                 1535         122,14.4   250,16.3    1.10(0.94--1.29)
  Female                                         806                 508          121,15.0    97,19.1    1.13(0.99--1.28)
  Days hospitalized, d                                                                                  
  ≤13                                            862                 1115         95,11.0    148,13.3    1.13(0.96--1.34)
  \>13                                           790                 928          148,18.7   199,21.4    1.10(0.96--1.26)
  Onset to hospital admission time, h                                                                   
  ≤24                                            719                 888          113,15.7   164,18.5    1.12(0.96--1.30)
  24--96                                         467                 543          82,17.6     87,16.0    0.95(0.80--1.12)
  \>96                                           466                 612          48,10.3     94,15.4    1.32(1.04--1.68)
  Smoker                                                                                                
  No                                            1137                 1148         169,14.9   195,17.0    1.09(0.96--1.22)
  Yes                                            515                 895          74,14.4    152,17.0    1.14(0.93--1.39)
  Drinker                                                                                               
  No                                            1226                 1319         191,15.6   229, 17.4   1.07(0.96--1.20)
  Yes                                            426                 724          52,12.2    118, 16.3   1.25(0.98--1.59)
  High BP                                                                                               
  No                                             788                 954          98,12.4    132, 13.8   1.07(0.91--1.26)
  Yes                                            864                 1089         145,16.8   215, 19.7   1.21(0.98--1.29)
  History of Hypertension                                                                               
  No                                             585                 658          91,15.6    101, 15.3   0.99(0.84--1.17)
  Yes                                           1067                 1385         152,14.2   246, 17.8   1.17(1.02--1.33)
  Hyperglycemia                                                                                         
  No                                             885                 1281         127,14.4   219, 17.1   1.14(0.98--1.32)
  Yes                                            767                 762          116,15.1   128,16.8    1.07(0.92--1.23)
  Dyslipidemia                                                                                          
  No                                             716                 908          128.17.9   157,17.3    0.98(0.85--1.13)
  Yes                                            936                 1135         115,12.3   190,16.7    1.23(1.06--1.44)

hHcy was defined as Hcy\>15 umol/l, and nhHcy was Hcy ≤15 umol/l.

We also analyzed the independent effect of admission blood pressure on poor outcome after acute ischemic stroke. The multivariable-adjusted OR (95% CI) of poor outcome was 1.44 (1.19--1.74). [Table 4](#pone-0107498-t004){ref-type="table"} summarizes the baseline characteristics of participants according to blood pressure and level of Hcy. Conventional risk factors, such as gender, days hospitalized, onset to hospital admission time, smoking, drinking, SBP, DBP, history of hypertension, history of hyperglycemia, history of coronary heart disease, history of atrial fibrillation, hyperglycemia, TG, TC and HDL cholesterol, were significantly different among the 4 groups. Namely, smoking, drinking, history of hyperglycemia, history of coronary heart disease, hyperglycemia, and TG were lower in those with hHcy in either high BP group. Hospitalized days, admission SBP, DBP, history of hypertension, diabetes mellitus percentage, TC, LDL cholesterol, and HDL cholesterol were higher in those with hHcy or nhHcy and high BP.

10.1371/journal.pone.0107498.t004

###### Baseline characteristics of participants according to blood pressure and level of Hcy.
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                                              Non-high BP nhHcy   Non-high BP hHcy   High BP nhHcy   High BP hHcy   P-value
  ------------------------------------------ ------------------- ------------------ --------------- -------------- ---------
  N                                                 1332                410              1449            504       
  Age                                             62.4±11.4          63.4±12.3         62.3±11.2      62.2±11.6      0.323
  Male no,%                                       806,60.51          342,83.41         848,58.52      385,76.39     \<0.001
  Days hospitalized (days)                        13.5±8.2            12.8±6.2         14.4±9.8        13.7±7.6      0.001
  Onset to hospital admission time (hours)       48(20,128)          56(24,120)       48(12,120)      48(10,124)    \<0.001
  Smoker no,%                                     477,35.81          209,50.98         476,32.85      248,49.21     \<0.001
  Drinker no,%                                    369,27.70          160,39.02         418,28.85      203,40.28     \<0.001
  Admission SBP (mmHg)                           128.2±11.5          127.9±10.6       161.9±29.4      162.7±18.2    \<0.001
  Admission DBP (mmHg)                            80.0±8.00          79.9±8.08         95.5±11.9      97.7±12.9     \<0.001
  History of Hypertension no,%                    701,52.63          236,57.56        1133,78.19      382,75.79     \<0.001
  History of Hyperglycemia no,%                   287,21.55           51,12.44         322,22.22       70,13.89     \<0.001
  History of coronary heart disease no,%          190,14.26           55,13.41         207,14.29       48,9.52       0.041
  History of atrial fibrillation no,%              27,2.03            12,2.93           25,1.73         2,0.40       0.029
  Glucose (mmol/l)                                6.69±4.21          6.48±4.33         6.90±2.88      6.52±2.48      0.058
  Hypertension no,%                               514,38.59          141,34.39         673,46.45      201,39.88     \<0.001
  Tg (mmol/l)                                     1.75±1.37          1.63±1.11         1.82±1.66      1.61±1.00      0.010
  Tc (mmol/l)                                     4.75±1.16          4.62±1.06         4.87±1.83      4.89±2.70      0.021
  LDL cholesterol (mmol/l)                        3.09±0.86          3.06±0.86         3.15±0.90      3.16±0.93      0.147
  HDL cholesterol (mmol/l)                        1.11±0.28          1.06±0.25         1.12±0.31      1.12±0.32      0.007
  Dyslipidemia no,%                               733,55.03          235,57.32         828,57.14      275,54.56      0.576

All values are expressed with mean±standard deviation unless otherwise noted. SBP, systolic blood pressure; DBP, diastolic blood pressure; Tg, triglycerides; Tc, total cholesterol; LDL, low-density lipoprotein; HDL, high-density lipoprotein; Hcy, homocysteine.

As shown in [table 5](#pone-0107498-t005){ref-type="table"}, compared to those with non-high BP and nhHcy, those with high BP in the nhHcy and hHcy groups were at higher risk of poor outcome following acute ischemic stroke: ORs (95%CIs) were 1.42 (1.08--1.87) and 1.73 (1.34--2.24), respectively. After adjustment for other confounding factors, the ORs (95%CIs) of non-high BP with hHcy, high BP with nhHcy, and high BP with hHcy groups were 1.14 (0.85--1.53), 1.37 (1.03--1.84), and 1.70 (1.29--2.34), respectively, compared with the non-high BP with nhHcy group. High BP with hHcy was associated with a higher risk of poor outcome. No significant interaction was detected between high BP and hHcy on poor outcome following acute ischemic stroke (*P* = 0.68).

10.1371/journal.pone.0107498.t005

###### Unadjusted and multivariable-adjusted odd ratios for poor outcome according to blood pressure and level of Hcy.
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                                          Unadjusted   Multivariable Adjusted[\*](#nt105){ref-type="table-fn"}                                
  ------------------- ------ ----------- ------------ --------------------------------------------------------- --------- ------ ------------ ---------
  Non-high BP/nhHcy    788    98,12.44       1.00                                \-                                        1.00       \-      
  Non-high BP/hHcy     954    132,13.84      1.13                            0.85--1.50                           0.392    1.14   0.85--1.53    0.384
  High BP/nhHcy        864    145,16.78      1.42                            1.08--1.87                           0.013    1.37   1.03--1.84    0.032
  High BP/hHcy         1089   215,19.74      1.73                            1.34--2.24                          \<0.001   1.70   1.29--2.34   \<0.001

\*Multivariable model adjusted for age, gender, days hospitalized, onset to hospital admission time, smoking, drinking, history of hypertension, history of hyperglycemia, history of coronary heart disease, history of atrial fibrillation, hyperglycemia, and dyslipidemia.

Discussion {#s4}
==========

In this study, we found that there was a positive and significant association between plasma Hcy concentration and poor discharge outcome among acute ischemic stroke patients. Additionally, the results indicated that blood pressure was an independent risk factor for poor outcome among acute ischemic stroke in this study. Meanwhile, those with high BP and nhHcy or with high BP and hHcy were at a significantly higher risk of poor outcome compared to those with non-high BP and nhHcy. Participants with high BP and hHcy were at the highest risk in this population. To the best of our knowledge, this is the first multi-center study conducted to assess the cumulative effect of high admission BP and Hcy concentration on poor discharge outcome following acute ischemia stroke in three northern cities of China. Compared with previous studies in which Hcy and blood pressure were each shown separately to predict prognosis of stroke [@pone.0107498-Wu1], [@pone.0107498-Song1], [@pone.0107498-Stead1], the novelty of our study lies in its combination of these two factors to form a new variable which tests the cumulative effect on the risk of poor outcome.

Several epidemiological studies indicated that elevated Hcy concentration is an important risk factor for short-term and long-term poor outcome following acute ischemia stroke [@pone.0107498-Naess1]--[@pone.0107498-Song1], [@pone.0107498-Pniewski1]. A prospective study by Tu et al. suggested that Hcy is an independent predictor of short-term outcome and mortality after acute ischemic stroke: the ORs (95%CIs) are 1.24 (1.10--1.39) and 1.14 (1.03--1.27), respectively [@pone.0107498-Tu1]. Naess et al.\'s cohort study indicated that there is an association between Hcy level and subsequent mortality in young adults in the years of following an ischemic stroke, even adjusting for traditional risk factors [@pone.0107498-Naess1]. Meanwhile, Pniewski et al. assessed the influence of Hcy level on the prognosis of stroke at onset and demonstrated that mild hyperhomocysteinemia (over 15 µmol/l) could increase the risk of poor recovery for stroke [@pone.0107498-Pniewski1]. These conclusions above were consistent with ours.

Some experimental studies indicate that Hcy may cause vascular inflammation and oxidative stress, damage endothelial cells, inhibit endothelium dependent relaxation, and enhance thrombogenicity [@pone.0107498-Faraci1]--[@pone.0107498-Zhang1]. Both minor genetic abnormalities and nutritional deficiencies of B vitamins, such as folic acid, involved in metabolism of methionine could lead to increased Hcy concentration. Wang et al.\'s meta-analysis indicated that folic supplementation significantly reduced the risk of stroke in primary prevention by 18% (RR 0.82, 95% CI 0.68--1.00; *P* = 0.045) [@pone.0107498-Wang1].

Increased BP in the acute stage of ischemic stroke may be associated with poor functional outcome because there is augmentation of cerebral edema, hemorrhagic transformation, or stroke recurrence [@pone.0107498-Stead1], [@pone.0107498-Tuttolomondo1], [@pone.0107498-lvarez1]. The International Stroke Trial (IST) demonstrated both high blood pressure and low blood pressure were independent prognostic factors for poor outcome [@pone.0107498-LeonardiBee1]. Our study indicated high BP was an independent risk factor for poor discharge outcome of acute ischemic stroke. Homocysteine may elevate blood pressure by causing arterial stiffness due to impaired vascular endothelial integrity and/or by reducing the efficiency of vasodilation [@pone.0107498-Wang2]. The National Health and Nutrition Examination Survey (NHANES), a nationally representative cross-sectional sample of the US population, showed that individuals with a combination of elevated total Hcy and hypertension were substantially more likely to have prevalent stroke compared to individuals without either condition (OR 12.02, 95%CI 6.36--22.73 for men and OR 17.34, 95%CI 10.49--28.64 for women), and the survey also indicated that elevated total Hcy and hypertension had a multiplicative effect on the odds of prevalent stroke [@pone.0107498-Towfighi1]. However, the cumulative effect of high BP and Hcy concentration on the risk of poor outcome is still unclear. Our data indicated that high BP with hHcy resulted in a higher risk for poor discharge outcome in this population, with a 1.70-fold increased risk compared with non-high BP with nhHcy. Elevated Hcy with high BP seems to increase the risk of poor outcome among acute ischemic stroke patients. The coexistence of elevated Hcy and high BP is a notable issue and suggests that lowering Hcy concentration may improve the prognosis of patients with acute ischemic stroke beyond antihypertensive treatment alone.

In the present study, the mean age of the participants was 62.40±11.45 years, which is lower than that in western countries [@pone.0107498-Feigin1], [@pone.0107498-Wang3]. The mean age of people with stroke is increasing worldwide, possibly due to an ageing population; however, a worrisome trend of increasing stroke incidence in young adults has been reported for some countries, especially in low-income developing nations [@pone.0107498-Feigin1]. This is largely attributable to the worldwide epidemic of hypertension and the increasing prevalence of smoking and other cardiovascular risk factors in young adults. Therefore, prevention is considered an effective strategy for both primary and secondary prevention of stroke. An overall healthy lifestyle, which includes not smoking, following a well-balanced diet, exercising regularly, drinking moderately, and controlling weight, may be effective in lowering blood pressure and other risk factors.

The potential limitations of this paper merit consideration. Firstly, blood pressure and plasma Hcy concentration were recorded only once at baseline, and we have no data on possible changes in blood pressure and Hcy concentration during the follow-up. Future studies should examine the association between blood pressure and Hcy concentration changes and prognosis of acute ischemic stroke. Secondly, all participants were recruited upon hospital admission and within 7 days of symptom onset, and due to this possible delay of up to 7 days since symptom onset, some patients\' Hcy concentration and blood pressure at admission may not accurately reflect the levels of Hcy and blood pressure at stroke onset. In addition, the follow-up period of our study is relatively short, which prevented an evaluation of the long-term effects of plasma Hcy on acute ischemic stroke outcomes.

In conclusion, our study suggested that high Hcy and blood pressure were independent risk factors for prognosis of acute ischemic stroke, and high Hcy may further increase the risk of poor outcome among patients with high blood pressure. Additionally, the results indicated that high Hcy with high BP may cause increased susceptibility to poor outcome among acute ischemic stroke patients in a northern Chinese population.
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